Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Paramus › NPI 1568858686
Clinic

City Medical of New Jersey, PC

City Medical of New Jersey, PC was paid $6.86M by Medicaid between Dec 2019 and Dec 2024, across 59 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.

33Billing provider infoCITY MEDICAL OF NEW JERSEY, PC
PARAMUS, NJ 07652
33aNPI1568858686assigned 04/15/2015
28Total paid$6.86M
24GClaims192,934
24DCodes billed59
24AFirst – last monthDec 2019 – Dec 2024
Compared with peers

Next to other Urgent Care Clinic/Center providers in New Jersey

Rank by total paid#2 of 60
Median peer was paid$255K
This provider vs. median27×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201913$580.21
202012,280$125K
202156,636$1.75M
202260,692$2.13M
202340,915$1.69M
2024incomplete22,398$1.17M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 32% 35,526 32,954 $2.21M
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 23% 28,041 27,431 $1.60M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 10% 10,599 10,136 $697K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 8.5% 8,892 8,016 $581K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 8.4% 56,513 53,083 $580K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 7.1% 7,776 7,639 $486K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 5.8% 6,987 6,858 $401K
S9083 Global fee urgent care centers 2.6% 4,452 3,995 $179K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 10,868 5,301 $56K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,360 5,166 $31K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 979 942 $10K
87428 <1% 2,684 2,531 $10K
47 more codes
81025 <1% 3,070 $5K
71046 Radiologic examination, chest; 2 views <1% 715 $4K
90715 <1% 110 $3K
93000 <1% 409 $3K
36415 Collection of venous blood by venipuncture <1% 2,714 $2K
90686 <1% 398 $2K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 21 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 517 $2K
73610 <1% 231 $1K
73630 <1% 203 $960.72
73562 <1% 75 $532.74
81002 <1% 2,667 $471.59
90656 <1% 35 $429.88
69210 <1% 46 $353.76
29130 <1% 28 $326.34
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 12 $300.00
73140 <1% 74 $259.30
86580 <1% 228 $253.05
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 110 $185.04
81003 <1% 924 $149.29
73110 <1% 12 $131.64
73030 <1% 13 $123.00
73130 <1% 40 $70.60
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 123 $21.43
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 123 $21.43
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 60 $6.56
86308 <1% 28 $5.00
81001 <1% 14 $4.43
82962 <1% 43 $4.00
87088 <1% 98 $3.24
87086 Culture, bacterial; quantitative colony count, urine <1% 94 $3.22
87070 <1% 119 $3.08
3079F 0% 18 $0.00
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 0% 86 $0.00
87340 0% 120 $0.00
86780 0% 87 $0.00
99000 0% 98 $0.00
3008F 0% 65 $0.00
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 0% 109 $0.00
1036F 0% 32 $0.00
3074F 0% 40 $0.00
86803 0% 121 $0.00
87077 0% 12 $0.00
3078F 0% 29 $0.00
87631 0% 28 $0.00
1160F 0% 44 $0.00
87186 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPARK, RICHARD (MANAGING OWNER)
Same official

Other billing entities under PARK, RICHARD

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.